P rotection of the ischemic heart has been the subject of experimental and clinical research for more than a decade. Myocardial infarct size is a function of cell necrosis occurring during ischemial and reperfusion,2 and numerous investigators have attempted to limit ischemic-and reperfusion-induced injury by pharmacological means. On balance, if the number of articles indicating successful intervention may be considered the arbiter of consensus, then it is unequivocal that ischemic-and reperfusion-induced injury can be attenuated pharmacologically and by induction of a preconditioning ischemic or thermal stress in experimental animal models. However, no drug has yet been approved for use as an "anti-ischemic" agent or as a cardioprotective adjunct to thrombolytic/angioplasty treatment (excepting antithrombotic drugs). The approach taken by Currie and colleagues, as reported in this issue of Circulation3 (and elsewhere4-7), to limit ischemic heart damage is unique in that protection of See p 963 the ischemic heart is afforded by an incompletely understood endogenous mechanism activated by wholebody heat shock. Raising the body temperature of anesthetized animals to 420C for a period of 15 minutes (heat shock) protects the heart against an ischemic insult.4 Currie and coworkers3 demonstrate that wholebody heat shock is protective against ischemia/reperfusion injury in vivo, confirming previous studies of cardioprotection against in vitro ischemic injury.4-6 Heat shock-mediated cardioprotection in vivo is transient, and the observed protective effect is no longer present 40 hours after application of the initial heat stress. The hypothesis supported by current3 and previous4'8.9 studies is that myocardial protection is related to the heat shock-mediated increase in cardiac heat shock protein synthesis.
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The term "heat shock protein" (HSP) refers to a group of proteins of which there are several families, differentiated by molecular weight (i.e., HSP An issue not addressed by Currie and colleagues is the effect of whole-body heat shock on extracardiac cells and the possible contribution of such effects to cardioprotection. The use of an in vivo ischemia/reperfusion paradigm introduces the possibility that whole-body heat shock affects noncardiac cells, tissue, or organ function that may impinge on cardiac susceptibility to ischemia-and reperfusion-induced damage. Although it is established that whole-body heat shock protects the heart from ischemia-reperfusion damage in vitro (indicative of a direct myocardial effect), the complexity of the in vivo milieu and the pancellular nature of the heat shock response imply that additional mechanisms must be considered. Altered neutrophil function is one possibility. In response to heat, neutrophil HSP expression is increased and neutrophil NADPH oxidase activation is inhibited, indicating that neutrophil superoxide production may be attenuated concomitant with increased HSP expression. 19 Since neutrophil ablation reduces infarct size,20 whole-body heat shock may confer cardioprotection in vivo in part by influencing neutrophil function. However, it is also possible that whole-body heat shock exerts negative effects because the duration of cardioprotection is much less in vivo than in vitro,7 and heat shock has failed to protect the heart in vivo. 17 Differentiation of the effect of heat shock on cardiac endothelial cells versus cardiac myocytes has not been addressed in studies that have shown cardioprotection by heat shock. The vascular endothelium plays a significant role in cardiac physiology and pathophysiology, and heat shock has been shown to increase HSP expression in vascular endothelial cells. 21 The relevance, if any, of a putative increase in endothelial HSP expression to cardioprotection is unknown. Furthermore, it remains to be determined if heat shock mediates a change in the expression of cardiac endothelial cell surface adhesion molecules. In view of the role of HSP in the cellular protection and trafficking of proteins22 and of the time course of both HSP expression and endothelial adhesion receptors23 during reperfusion of the previously ischemic heart, a relation may exist between HSP and cell surface adhesion receptor expression. As alluded to above, such a relation may not be beneficial.
Currie et a13 show that whole-body heat shock "affords an ATP-sparing effect" and the preservation of tissue ATP may contribute to 
